Long non-coding RNA (lncRNA), Structural component of paraspeckles, Other
01
Overview
Nuclear paraspeckle assembly transcript 1 (NEAT1) is a long non-coding RNA that serves as the scaffolding structural molecule necessary for the formation of paraspeckles, a type of membraneless nuclear body involved in the spatial regulation of gene expression[1][6][7]. NEAT1 exists in two major isoforms: NEAT1_1 (~3,700 nt) and NEAT1_2 (~23,000 nt), with NEAT1_2 being essential for paraspeckle formation in mammals[1][4]. NEAT1 modulates cellular stress responses via sequestration of various transcription/regulatory proteins, influences chromatin structure, and acts as a competing endogenous RNA to control microRNA networks[2][5]. Its expression is dynamically regulated in response to multiple stressors including viral infection, proteasome inhibition, and mechanical stimuli[1][3][4]. NEAT1 is implicated as a central regulatory hub in oncogenesis, autoimmunity, and other stress-related conditions, making it a promising biomarker and therapeutic target for cancer and inflammatory diseases[2][5][6].
Knockdown by siRNA/shRNA: inhibits NEAT1 expression and paraspeckle assembly[2]. Antisense oligonucleotides (ASOs): disrupt NEAT1 and paraspeckle formation[1]. Epigenetic modulation: drugs impacting DNA methylation or Polycomb repressive complex (EZH2) may indirectly affect NEAT1's network[2].
03
Biological functions
Paraspeckle nuclear body assemblyTranscriptional regulation through protein sequestrationScaffold for protein (e.g., SFPQ, NONO) bindingChromatin modificationCell cycle regulationApoptosis attenuationRegulation of immune cell function (e.g., Th17 response)DNA damage repair system regulationMechanosensor in cells (e.g., osteoblasts)Promotion of cell migration and invasionChemoresistance/radioresistance in cancer
Potential for unintended interference with essential nuclear structure leading to global alterations in gene expression[1].Off-target effects in non-tumor tissues due00000000000 to NEAT1's widespread expression[7].Effects on fertility and lactation reported in knockout mice[7].
06
Interacting drugs
No approved drugs directly target NEAT1, but small interfering RNAs (siRNAs) and short hairpin RNAs (shRNAs) targeting NEAT1 have shown effects in preclinical models[2].
1 more in the full profile.
07
Biomarkers
NEAT1 expression level (diagnostic and prognostic marker for several cancers)[2][8].Paraspeckle morphology and abundance in relevant tissues/cells[1][3].
Beyond the preview
Go deeper on Nuclear paraspeckle assembly transcript 1 (NEAT1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nuclear paraspeckle assembly transcript 1 (NEAT1).